Search results for: Institute for Clinical and Economic Review (ICER)
Filter search results
New Publication: Headroom Approach to Device Development
23 February 2016
…of a pharmaceutical product; these differences have important implications for both the developer and the health care decision-maker tasked with assessing its value to patients and the NHS (Chapman, 2014)….
Framing Effects and Study Design Considerations in Stated Preference Research
1 December 2017
…should seek to control for such effects when seeking to examine people’s health care priority setting preferences. Preferences for an End of Life ‘Premium‘: An Examination of Framing Effects and…
Cancer Survivorship Burden
6 March 2018
A new paper entitled “Survivorship Burden for Individuals, Households and Society: Estimates and Methodology” has been published in the Journal of Cancer Policy. An article by OHE’s Paula Lorgelly and…
A Critique of Hill et al. (2018) on Estimated Costs of Production for the WHO Essential Medicines List
19 May 2018
…reviews “Estimated costs of production and potential prices of medicines for the World Health Organization Essential Medicines List” (Hill et al., 2018) in which the authors argue for “greater transparency…
New Paper in Value in Health: Improving the Quality of Time Trade-Off Data
27 June 2018
…for obtaining values for health states for use in health technology assessment. NICE recommends that the value, or utility, of changes in health should be based on public preferences elicited…
Measuring UK Medicines Expenditure in the Context of the 2014-18 PPRS
29 August 2018
…for the English National Health Service (NHS) for the same period at 8.0%. However, NHS Digital reported much-reduced medicines expenditure growth for England of 3.5% for 2016/17, suggesting a complex…
OHE Lunchtime Seminar: Cascades of Care in Health Policy Analysis and Planning
26 March 2019
…hepatitis C. He has been a staff member of the IMF and has advised governments and international agencies such as UNAIDS and the World Bank. His book on The Economics…
Quality of Life and Rare Disease: Lessons from Spinal Muscular Atrophy
2 April 2019
…for rare diseases. For more information, contact Chris Sampson. Sampson, C. and Garau, M., 2019. How Should We Measure Quality of Life Impact in Rare Disease? Recent Learnings in Spinal…
Adult Versus Adolescent Preferences for EQ-5D-Y Health States
15 April 2019
Koonal Shah gave a webinar for the International Health Economics Association on the topic of adult versus adolescent preferences for EQ-5D-Y health states. The International Health Economics Association (iHEA) recently…